Genomic instability and carcinogenesis: An update

Current Genomics

Volumn 9, Issue 8, 2008, Pages 535-541

  Abdel Rahman, Wael M ^a  

^a UNIVERSITY OF SHARJAH   (United Arab Emirates)

Author keywords

Chromosomal instability; Colorectal cancer; Familial colectal cancer type X; Genetic instability; Genomic instability; HNPCC; Lynch syndrome; Microsatellite instability; Mismatch repair

Indexed keywords

DNA; PROTEIN MLH1;

CLINICAL FEATURE; COLON CARCINOGENESIS; COLONOSCOPY; COLORECTAL CARCINOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EVIDENCE BASED PRACTICE; FAMILIAL CANCER; GENE MUTATION; GENE NUMBER; GENE SEQUENCE; GENETIC PREDISPOSITION; GENOMIC INSTABILITY; GENOTYPE PHENOTYPE CORRELATION; HIGH THROUGHPUT SCREENING; HISTOPATHOLOGY; HUMAN; MATHEMATICAL MODEL; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MUTATIONAL ANALYSIS; NATURAL SELECTION; PHENOTYPE; PRACTICE GUIDELINE; REVIEW;

EID: 65949086579     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920208786847926     Document Type: Review

References (77)

1. Mitelman, F., Johansson, B., Mertens, F. Mitelman database of chromosome aberrations in cancer. http://cgap.nci.gov/chromosomes/Mitelman. 2006.
2. Myllykangas, S., Himberg, J., Bohling, T., Nagy, B., Hollmen, J., Knuutila, S. DNA copy number amplification profiling of human neoplasms. Oncogene 2006, 25: 7324-7332.
3. Gaasenbeek, M., Howarth, K., Rowan, A.J., Gorman, P.A., Jones, A., Chaplin, T., Liu, Y., Bicknell, D., Davison, E.J., Fiegler, H., Carter, N.P., Roylance, R.R., Tomlinson, I.P. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers. Cancer Res. 2006, 66: 3471-3479.
4. Abdel-Rahman, W.M., Ollikainen, M., Kariola, R., Jarvinen, H.J., Mecklin, J.P., Nystrom-Lahti, M., Knuutila, S., Peltomaki, P. Comprehensive characterization of HNPCC-related colorectal cancers reveals striking molecular features in families with no germline mismatch repair gene mutations. Oncogene 2005, 24: 1542-1551.
5. Sjoblom, T., Jones, S., Wood, L.D., Parsons, D.W., Lin, J., Barber, T.D., Mandelker, D., Leary, R.J., Ptak, J., Silliman, N., Szabo, S., Buckhaults, P., Farrell, C., Meeh, P., Markowitz, S.D., Willis, J., Dawson, D., Willson, J.K., Gazdar, A.F., Hartigan, J., Wu, L., Liu, C., Parmigiani, G., Park, B.H., Bachman, K.E., Papadopoulos, N., Vogelstein, B., Kinzler, K.W., Velculescu, V.E. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314: 268-274.
6. Abdel-Rahman, W.M., Mecklin, J.P., Peltomaki, P. The genetics of HNPCC: application to diagnosis and screening. Crit. Rev. Oncol. Hematol. 2006, 58: 208-220.
7. Lengauer, C., Kinzler, K.W., Vogelstein, B. Genetic instability in colorectal cancers. Nature 1997, 386: 623-627.
8. Lengauer, C., Kinzler, K.W., Vogelstein, B. Genetic instabilities in human cancers. Nature 1998, 396: 643-649.
9. Cahill, D.P., Kinzler, K.W., Vogelstein, B., Lengauer, C. Genetic instability and Darwinian selection in tumours. Trends Biochem. Sci. 1999, 24: 57-M60.
10. Michor, F., Iwasa, Y., Vogelstein, B., Lengauer, C., Nowak, M.A. Can chromosomal instability initiate tumorigenesis? Semin. Cancer Biol. 2005, 15: 43-49.
11. Rajagopalan, H., Nowak, M.A., Vogelstein, B., Lengauer, C. The significance of unstable chromosomes in colorectal cancer. Nat. Rev. Cancer 2003, 3: 695-701.
12. Abdel-Rahman, W.M., Peltomaki, N. Molecular basis and diagnostics of hereditary colorectal cancers. Ann. Med. 2004, 36: 379-388.
13. Jass, J.R. Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat. Clin. Pract. Oncol. 2005, 2: 398-405.
14. Jass, J.R. Heredity and DNA methylation in colorectal cancer. Gut 2007, 56: 154-155.
15. Bielas, J.H., Loeb, K.R., Rubin, B.P., True, L.D., Loeb, L.A. Human cancers express a mutator phenotype. Proc. Natl. Acad. Sci. USA 2006, 103: 18238-18242.
16. Abdel-Rahman, W.M., Katsura, K., Rens, W., Gorman, P.A., Sheer, D., Bicknell, D., Bodmer, W.F., Arends, M.J., Wyllie, A.H., Edwards, P.A. Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement. Proc. Nat. Acad. Sci. USA 2001, 98: 2538-2543.
17. Georgiades, I.B., Curtis, L.J., Morris, R.M., Bird, C.C., Wyllie, A.H. Heterogeneity studies identify a subset of sporadic colorectal cancers without evidence for chromosomal or microsatellite instability. Oncogene 1999, 18: 7933-7940.
18. Chan, T.L., Curtis, L.C., Leung, S.Y., Farrington, S.M., Ho, J.W.C., Chan, A.S.Y., Lam, P.W.Y., Tse, C.W., Dunlop, M.G., Wyllie, A.H., Yuen, S.T. Early-onset colorectal cancer with stable microsatellite DNA and near-diploid chromosomes. Oncogene 2001, 20: 4871-4876.
19. Jones, A.M., Douglas, E.J., Halford, S.E.R., Fiegler, H., Gorman, P.A., Roylance, R.R., Carter, N.P., Tomlinson, I.P.M. Array-CGH analysis of microsatellite-stable, near-diploid bowel cancers and comparison with other types of colorectal carcinoma. Oncogene 2005, 24: 118-129.
20. Abdel-Rahman, W.M., Georgiades, I.B., Curtis, L.J., Arends, M.J., Wyllie, A.H. Role of BAX mutations in mismatch repair-deficient colorectal carcinogenesis. Oncogene 1999, 18: 2139-2142.
21. Loeb, L.A., Bielas, J.H., Beckman, R.A. Cancers exhibit a mutator phenotype: clinical implications. Cancer Res. 2008, 68: 3551-3557; discussion 3557.
22. Loeb, L.A., Loeb, K.R., Anderson, J.P. Multiple mutations and cancer. Proc. Natl. Acad. Sci. USA 2003, 100: 776-781.
23. Loeb, L.A. Cancer cells exhibit a mutator phenotype. Adv. Cancer Res. 1998, 72: 25-56.
24. Loeb, L.A. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res. 1994, 54: 5059-5063.
25. Loeb, K.R., Loeb, L.A. Significance of multiple mutations in cancer. Carcinogenesis 2000, 21: 379-385.
26. Cahill, D.P., Lengauer, C., Yu, J., Riggins, G.J., Willson, J.K.V., Markowitz, S.D., Kinzler, K.W., Vogelstein, B. Mutations of mitotic checkpoint genes in human cancers. Nature 1998, 392: 300-303.
27. Abdel-Rahman, W.M., Knuutila, S., Peltomaki, P., Harrison, D.J., Bader, S.A. Truncation of MBD4 predisposes to reciprocal chromosomal translocations and alters the response to therapeutic agents in colon cancer cells. DNA Repair (Amst) 2008, 7: 321-328.
28. Grigorova, M., Staines, J.M., Ozdag, H., Caldas, C., Edwards, P.A. Possible causes of chromosome instability: comparison of chromosomal abnormalities in cancer cell lines with mutations in BRCA1, BRCA2, CHK2 and BUB1. Cytogenet. Genome Res. 2004, 104: 333-340.
29. Tomlinson, I.P., Novelli, M.R., Bodmer, W.F. The mutation rate and cancer. Proc. Natl. Acad. Sci. USA 1996, 93: 14800-14803.
30. Tomlinson, I., Bodmer, W. Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog. Nat. Med. 1999, 5: 11-12.
31. Tomlinson, I., Sasieni, P., Bodmer, W. How many mutations in a cancer? Am. J Pathol. 2002, 160: 755-758.
32. Bodmer, W. Genetic instability is not a requirement for tumor development. Cancer Res. 2008, 68: 3558-3560.
33. Jones, A.M., Thirlwell, C., Howarth, K.M., Graham, T., Chambers, W., Segditsas, S., Page, K.M., Phillips, R.K., Thomas, H.J., Sieber, O.M., Sawyer, E.J., Tomlinson, I.P. Analysis of copy number changes suggests chromosomal instability in a minority of large colorectal adenomas. J. Pathol. 2007, 213: 249-256.
34. Abdel-Rahman, W.M., Lohi, H., Knuttila, S., Peltomaki, P. Restoring mismatch repair does not stop the formation of reciprocal translocations in the colon cancer cell line HCA7 but further destabilizes chromosome number. Oncogene 2005, 24: 706-713.
35. Roschke, A.V., Stover, K., Tonon, G., Schaffer, A.A., Kirsch, I.R. Stable karyotypes in epithelial cancer cell lines despite high rates of ongoing structural and numerical chromosomal instability. Neoplasia 2002, 4: 19-31.
36. Losi, L., Baisse, B., Bouzourene, H., Benhattar, J. Evolution of intratumoral genetic heterogeneity during colorectal cancer progression. Carcinogenesis 2005, 26: 916-922.
37. Beerenwinkel, N., Antal, T., Dingli, D., Traulsen, A., Kinzler, K.W., Velculescu, V.E., Vogelstein, B., Nowak, M.A. Genetic progression and the waiting time to cancer. PLoS Comput. Biol. 2007, 3: 225.
38. Vasen, H.F.A., Mecklin, J.P., Khan, P.M., Lynch, H.T. The International Collaborative Group on hereditary nonpolyposis colorectal cancer (ICG-HNPCC). Dis. Colon Rectum 1991, 34: 424-425.
39. Popat, S., Hubner, R., Houlston, R.S. Systematic review of microsatellite instability and colorectal cancer prognosis. J. Clin. Oncol. 2005, 23: 609-618.
40. Mecklin, J.P., Järvinen, H.J. Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer). Cancer 1991, 68: 1109-1112.
41. Jass, J.R., Smyrk, T.C., Stewart, S.M., Lane, M.R., Lanspa, S.J., Lynch, H.T. Pathology of hereditary non-polyposis colorectal cancer. Anticancer Res. 1994, 14: 1631-1634.
42. Smyrk, T.C., Watson, P., Kaul, K., Lynch, H.T. Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer 2001, 91: 2417-2422.
43. Jass, J.R. Role of the pathologist in the diagnosis of hereditary nonpolyposis colorectal cancer. Dis. Markers 2004, 20: 215-224.
44. Vasen, H.F., Watson, P., Mecklin, J.-P., Lynch, H.T. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterol. 1999, 116: 1453-1456.
45. Umar, A., Boland, C.R., Terdiman, J.P., Syngal, S., de la Chapelle, A., Ruschoff, J., Fishel, R., Lindor, N.M., Burgart, L.J., Hamelin, R., Hamilton, S.R., Hiatt, R.A., Jass, J., Lindblom, A., Lynch, H.T., Peltomäki, P., Ramsey, S.D., Rodriguez-Bigas, M.A., Vasen, H.F.A., Hawk, E.T., Barrett, J.C., Freedman, A.N., Srivastava, S. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J. Nat. Cancer Inst. 2004, 96: 261-268.
46. Barnetson, R.A., Tenesa, A., Farrington, S.M., Nicholl, I.D., Cetnarskyj, R., Porteous, M.E., Campbell, H., Dunlop, M.G. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N. Engl. J. Med. 2006, 354: 2751-2763.
47. Balmana, J., Stockwell, D.H., Steyerberg, E.W., Stoffel, E.M., Deffenbaugh, A.M., Reid, J.E., Ward, B., Scholl, T., Hendrickson, B., Tazelaar, J., Burbidge, L.A., Syngal, S. Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA 2006, 296: 1469-1478.
48. Chen, S., Wang, W., Lee, S., Nafa, K., Lee, J., Romans, K., Watson, P., Gruber, S.B., Euhus, D., Kinzler, K.W., Jass, J., Gallinger, S., Lindor, N.M., Casey, G., Ellis, N., Giardiello, F.M., Offit, K., Parmigiani, G. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 2006, 296: 1479-1487.
49. Balaguer, F., Balmana, J., Castellvi-Bel, S., Steyerberg, E.W., Andreu, M., Llor, X., Jover, R., Syngal, S., Castells, A. Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients. Gastroenterol. 2008, 134: 39-46.
50. Wu, Y., Berends, M.J.W., Sijmons, R.H., Mensink, R.G.J., Verlind, E., Kooi, K.A., van der Sluis, T., Kempinga, C., van der Zee, A.G.J., Hollema, H., Buys, C., Kleibeuker, J.H., Hofstra, R.M.W. A role for MLH3 in hereditary nonpolyposis colorectal cancer. Nat. Genet. 2001, 29: 137-138.
51. Liu, H.X., Zhou, X.L., Liu, T., Werelius, B., Lindmark, G., Dahl, N., Lindblom, A. The role of hMLH3 in familial colorectal cancer. Cancer Res. 2003, 63: 1894-1899.
52. Hienonen, T., Laiho, P., Salovaara, R., Mecklin, J.P., Jarvinen, H., Sistonen, P., Peltomaki, P., Lehtonen, R., Nupponen, N.N., Launonen, V., Karhu, A., Aaltonen, L.A. Little evidence for involvement of MLH3 in colorectal cancer predisposition. Int. J. Cancer 2003, 106: 292-296.
53. Peltomäki, P., Vasen, H. Mutations associated with HNPCC predisposition - Update of ICG-HNPCC/insight mutation database. Dis. Markers 2004, 20: 269-276.
54. Valle, L., Carbonell, P., Fernandez, V., Dotor, A.M., Sanz, M., Benitez, J., Urioste, M. MLH1 germline epimutations in selected patients with early-onset non-polyposis colorectal cancer. Clin. Genet. 2007, 71: 232-237.
55. Hitchins, M., Williams, R., Cheong, K., Halani, N., Lin, V.A., Packham, D., Ku, S., Buckle, A., Hawkins, N., Burn, J., Gallinger, S., Goldblatt, J., Kirk, J., Tomlinson, I., Scott, R., Spigelman, A., Suter, C., Martin, D., Suthers, G., Ward, R. MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. Gastroenterol. 2005, 129: 1392-1399.
56. Hitchins, M.P., Wong, J.J., Suthers, G., Suter, C.M., Martin, D.I., Hawkins, N.J., Ward, R.L. Inheritance of a cancer-associated MLH1 germ-line epimutation. N. Engl. J. Med. 2007, 356: 697-705.
57. Chan, T.L., Yuen, S.T., Kong, C.K., Chan, Y.W., Chan, A.S., Ng, W.F., Tsui, W.Y., Lo, M.W., Tam, W.Y., Li, V.S., Leung, S.Y. Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Nat. Genet. 2006, 38: 1178-1183.
58. Suter, C.M., Martin, D.I., Ward, R.L. Germline epimutation of MLH1 in individuals with multiple cancers. Nat. Genet. 2004, 36: 497-501.
59. Gonzalo, V., Castellvi-Bel, S., Castells, A. MLH1 germ-line epimutations: is there strong evidence of its inheritance? Gastroenterol. 2007, 133: 1042-1044.
60. Parsons, R., Li, G.M., Longley, M.J., Fang, W.H., Papadopoulos, N., Jen, J., Delachapelle, A., Kinzler, K.W., Vogelstein, B., Modrich, P. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993, 75: 1227-1236.
61. Hemminki, A., Peltomäki, P., Mecklin, J.P., Järvinen, H., Salovaara, R., Nyström-Lahti, M., de la Chapelle, A., Aaltonen, L.A. Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorecta cancer. Nat. Genet. 1994, 8: 405-410.
62. Liu, B., Parsons, R.E., Hamilton, S.R., Petersen, G.M., Lynch, H.T., Watson, P., Markowitz, S., Willson, J.K.V., Green, J., de la Chapelle, A., Kinzler, K.W., Vogelstein, B. hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res. 1994, 54: 4590-4594.
63. Kuismanen, S.A., Holmberg, M.T., Salovaara, R., de la Chapelle, A., Peltomäki, P. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Am. J. Pathol. 2000, 156: 1773-1779.
64. Kuismanen, S.A., Holmberg, M.T., Salovaara, R., Schweizer, P., Aaltonen, L.A., de la Chapelle, A., Nystrom-Lahti, M., Peltomaki, P. Epigenetic phenotypes distinguish microsatellite stable and unstable colorectal cancers. Proc. Natl. Acad. Sci. USA 1999, 96: 12661-12666.
65. Duval, A., Iacopetta, B., Ranzani, G.N., Lothe, R.A., Thomas, G., Hamelin, R. Variable mutation frequencies in coding repeats of TCF-4 and other target genes in colon, gastric and endometrial carcinoma showing microsatellite instability. Oncogene 1999, 18: 6806-6809.
66. Ionov, Y., Peinado, M.A., Malkhosyan, S., Shibata, D., Perucho, M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993, 363: 558-561.
67. Yamamoto, H., Imai, K., Perucho, M. Gastrointestinal cancer of the microsatellite mutator phenotype pathway. J. Gastroenterol. 2002, 37: 153-163.
68. Nyström-Lahti, M., Wu, Y., Moisio, A.L., Hofstra, R.M.W., Osinga, J., Mecklin, J.P., Järvinen, H.J., Leisti, J., Buys, C., de la Chapelle, A., Peltomäki, P. DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum. Mol. Genet. 1996, 5: 763-769.
69. Wijnen, J., Khan, P.M., Vasen, H., vanderKlift, H., Mulder, A., van Leeuwen Cornelisse, I., Bakker, B., Losekoot, M., Moller, P., Fodde, R. Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch repair gene mutations. Am. J. Hum. Genet. 1997, 61: 329-335.
70. Renkonen, E., Zhang, Y.G., Lohi, H., Salovaara, R., Abdel-Rahman, W.M., Nilbert, M., Aittomaki, K., Järvinen, H.J., Mecklin, J.P., Lindblom, A., Peltomäki, P. Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer. J. Clin. Oncol. 2003, 21: 3629-3637.
71. Bisgaard, M.L., Jager, A.C., Myrhoj, T., Bernstein, I., Nielsen, F.C. Hereditary non-polyposis colorectal cancer (HNPCC): Phenotype-genotype correlation between patients with and without indentified mutation. Hum. Mutat. 2002, 20: 20-27.
72. Benatti, P., Roncucci, L., Ganazzi, D., Percesepe, A., Di Gregorio, C., Pedroni, M., Borghi, F., Sala, E., Scarselli, A., Menigatti, M., Rossi, G., Genuardi, M., Viel, A., Ponz de Leon, M. Clinical and biologic heterogeneity of hereditary nonpolyposis colorectal cancer. Int. J. Cancer 2001, 95: 323-328.
73. Lindor, N.M., Rabe, K., Petersen, G.M., Haile, R., Casey, G., Baron, J., Gallinger, S., Bapat, B., Aronson, M., Hopper, J., Jass, J., LeMarchand, L., Grove, J., Potter, J., Newcomb, P., Terdiman, J.P., Conrad, P., Moslein, G., Goldberg, R., Ziogas, A., Anton-Culver, H., de Andrade, M., Siegmund, K., Thibodeau, S.N., Boardman, L.A., Seminara, D. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency - Familial colorectal cancer type X. JAMA 2005, 293: 1979-1985.
74. Sanchez-de-Abajo, A., de la Hoya, M., van Puijenbroek, M., Tosar, A., Lopez-Asenjo, J.A., Diaz-Rubio, E., Morreau, H., Caldes, T. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways. Clin. Cancer Res. 2007, 13: 5729-5735.
75. Frazier, M.L., Xi, L.X., Zong, J.H., Viscofsky, N., Rashid, A., Wu, E.F., Lynch, P.M., Amos, C.I., Issa, J.P.J. Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer. Cancer Res. 2003, 63: 4805-4808.
76. Ricciardiello, L., Goel, A., Mantovani, V., Fiorini, T., Fossi, S., Chang, D.K., Lunedei, V., Pozzato, P., Zagari, R.M., De Luca, L., Fuccio, L., Martinelli, G.N., Roda, E., Boland, C.R., Bazzoli, F. Frequent loss of hMLH1 by promoter hypermethylation leads to microsatellite instability in adenomatous polyps of patients with a single first-degree member affected by colon cancer. Cancer Res. 2003, 63: 787-792.
77. Domingo, E., Laiho, P., Ollikainen, M., Pinto, M., Wang, L., French, A.J., Westra, J., Frebourg, T., Espin, E., Armengol, M., Hamelin, R., Yamamoto, H., Hofstra, R.M.W., Seruca, R., Lindblom, A., Peltomaki, P., Thibodeau, S.N., Aaltonen, L.A., Schwartz, S. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J. Med. Genet. 2004, 41: 664-668.